| Dr Caroline Reynolds Mitchell, MD | |
|
8901 Carti Way, Little Rock, AR 72205-6523 | |
| (501) 906-3000 | |
| (501) 907-8367 |
| Full Name | Dr Caroline Reynolds Mitchell |
|---|---|
| Gender | Female |
| Speciality | Anesthesiology |
| Experience | 15 Years |
| Location | 8901 Carti Way, Little Rock, Arkansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215161054 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | E-8991 (Arkansas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southern Regional Anesthesiology Consultants Pllc | 2961633870 | 71 |
| Central Arkansas Radiation Therapy Institute Inc | 7810068400 | 72 |
News Archive
A new study has found a possible mechanism for tamoxifen resistance in breast cancer and provides evidence that another cancer drug-gefitinib (Iressa)-may be able to restore tamoxifen's anticancer activity.
A single minute of exercise each day is linked to better bone health in women, new research shows.
Heart failure is a leading cause of maternal morbidity and death in the U.S. - with the rate of pregnancy-related deaths more than doubling between 1987 and 2011. Even so, much about heart failure-related hospitalizations before, during and after delivery is unknown.
ArQule, Inc. (Nasdaq: ARQL) today announced that patient enrollment in a Phase 2 trial with ARQ 197 in non-small cell lung cancer (NSCLC) has been completed.
› Verified 2 days ago
| Entity Name | University Of Arkansas For Medical Sciences |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588654016 PECOS PAC ID: 4082528955 Enrollment ID: O20031219000706 |
News Archive
A new study has found a possible mechanism for tamoxifen resistance in breast cancer and provides evidence that another cancer drug-gefitinib (Iressa)-may be able to restore tamoxifen's anticancer activity.
A single minute of exercise each day is linked to better bone health in women, new research shows.
Heart failure is a leading cause of maternal morbidity and death in the U.S. - with the rate of pregnancy-related deaths more than doubling between 1987 and 2011. Even so, much about heart failure-related hospitalizations before, during and after delivery is unknown.
ArQule, Inc. (Nasdaq: ARQL) today announced that patient enrollment in a Phase 2 trial with ARQ 197 in non-small cell lung cancer (NSCLC) has been completed.
› Verified 2 days ago
| Entity Name | University Of Arkansas For Medical Sciences |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346230968 PECOS PAC ID: 4082528955 Enrollment ID: O20040115000431 |
News Archive
A new study has found a possible mechanism for tamoxifen resistance in breast cancer and provides evidence that another cancer drug-gefitinib (Iressa)-may be able to restore tamoxifen's anticancer activity.
A single minute of exercise each day is linked to better bone health in women, new research shows.
Heart failure is a leading cause of maternal morbidity and death in the U.S. - with the rate of pregnancy-related deaths more than doubling between 1987 and 2011. Even so, much about heart failure-related hospitalizations before, during and after delivery is unknown.
ArQule, Inc. (Nasdaq: ARQL) today announced that patient enrollment in a Phase 2 trial with ARQ 197 in non-small cell lung cancer (NSCLC) has been completed.
› Verified 2 days ago
| Entity Name | Arkansas Childrens Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598773079 PECOS PAC ID: 2769477744 Enrollment ID: O20040419000796 |
News Archive
A new study has found a possible mechanism for tamoxifen resistance in breast cancer and provides evidence that another cancer drug-gefitinib (Iressa)-may be able to restore tamoxifen's anticancer activity.
A single minute of exercise each day is linked to better bone health in women, new research shows.
Heart failure is a leading cause of maternal morbidity and death in the U.S. - with the rate of pregnancy-related deaths more than doubling between 1987 and 2011. Even so, much about heart failure-related hospitalizations before, during and after delivery is unknown.
ArQule, Inc. (Nasdaq: ARQL) today announced that patient enrollment in a Phase 2 trial with ARQ 197 in non-small cell lung cancer (NSCLC) has been completed.
› Verified 2 days ago
| Entity Name | St Vincent Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134176480 PECOS PAC ID: 5698758803 Enrollment ID: O20040622000224 |
News Archive
A new study has found a possible mechanism for tamoxifen resistance in breast cancer and provides evidence that another cancer drug-gefitinib (Iressa)-may be able to restore tamoxifen's anticancer activity.
A single minute of exercise each day is linked to better bone health in women, new research shows.
Heart failure is a leading cause of maternal morbidity and death in the U.S. - with the rate of pregnancy-related deaths more than doubling between 1987 and 2011. Even so, much about heart failure-related hospitalizations before, during and after delivery is unknown.
ArQule, Inc. (Nasdaq: ARQL) today announced that patient enrollment in a Phase 2 trial with ARQ 197 in non-small cell lung cancer (NSCLC) has been completed.
› Verified 2 days ago
| Entity Name | Central Arkansas Radiation Therapy Institute Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508147810 PECOS PAC ID: 7810068400 Enrollment ID: O20111019000931 |
News Archive
A new study has found a possible mechanism for tamoxifen resistance in breast cancer and provides evidence that another cancer drug-gefitinib (Iressa)-may be able to restore tamoxifen's anticancer activity.
A single minute of exercise each day is linked to better bone health in women, new research shows.
Heart failure is a leading cause of maternal morbidity and death in the U.S. - with the rate of pregnancy-related deaths more than doubling between 1987 and 2011. Even so, much about heart failure-related hospitalizations before, during and after delivery is unknown.
ArQule, Inc. (Nasdaq: ARQL) today announced that patient enrollment in a Phase 2 trial with ARQ 197 in non-small cell lung cancer (NSCLC) has been completed.
› Verified 2 days ago
| Entity Name | Southern Regional Anesthesiology Consultants Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902231673 PECOS PAC ID: 2961633870 Enrollment ID: O20140318000757 |
News Archive
A new study has found a possible mechanism for tamoxifen resistance in breast cancer and provides evidence that another cancer drug-gefitinib (Iressa)-may be able to restore tamoxifen's anticancer activity.
A single minute of exercise each day is linked to better bone health in women, new research shows.
Heart failure is a leading cause of maternal morbidity and death in the U.S. - with the rate of pregnancy-related deaths more than doubling between 1987 and 2011. Even so, much about heart failure-related hospitalizations before, during and after delivery is unknown.
ArQule, Inc. (Nasdaq: ARQL) today announced that patient enrollment in a Phase 2 trial with ARQ 197 in non-small cell lung cancer (NSCLC) has been completed.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Caroline Reynolds Mitchell, MD 500 S University Ave Ste 500, Little Rock, AR 72205-5307 Ph: (501) 664-4532 | Dr Caroline Reynolds Mitchell, MD 8901 Carti Way, Little Rock, AR 72205-6523 Ph: (501) 906-3000 |
News Archive
A new study has found a possible mechanism for tamoxifen resistance in breast cancer and provides evidence that another cancer drug-gefitinib (Iressa)-may be able to restore tamoxifen's anticancer activity.
A single minute of exercise each day is linked to better bone health in women, new research shows.
Heart failure is a leading cause of maternal morbidity and death in the U.S. - with the rate of pregnancy-related deaths more than doubling between 1987 and 2011. Even so, much about heart failure-related hospitalizations before, during and after delivery is unknown.
ArQule, Inc. (Nasdaq: ARQL) today announced that patient enrollment in a Phase 2 trial with ARQ 197 in non-small cell lung cancer (NSCLC) has been completed.
› Verified 2 days ago
Faber A White, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1701 S Shackleford Rd, Little Rock, AR 72211 Phone: 501-219-7481 | |
Louis W Sessions, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 9601 Interstate 630 Exit 7, Little Rock, AR 72205 Phone: 501-202-2093 | |
David M Dean, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 9601 Interstate 630 Exit 7, Little Rock, AR 72205 Phone: 501-202-2093 | |
Ken Wade, CRNA Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 9601 Interstate 630 Exit 7, Little Rock, AR 72205 Phone: 501-202-2093 | |
Garry Jones, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 500 S University Ave, Suite 505, Little Rock, AR 72205 Phone: 501-664-4532 Fax: 501-663-4335 | |
Mrs. Tatiana Puntarelli, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 1 Childrens Way # 203, Little Rock, AR 72202 Phone: 501-364-1100 Fax: 501-364-4082 | |
Gregory Ryan Mehaffey, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 4301 W Markham St # 783, Little Rock, AR 72205 Phone: 501-686-8000 |